Abstract | OBJECTIVES: METHODS: Prospective, double-blind, noninferiority randomized controlled trial based in 1 tertiary pediatric emergency department and 1 urban district emergency department in Perth, Western Australia. Inclusions were age >6 months, maximum weight 20 kg, contactable by telephone, and English-speaking caregivers. Exclusion criteria were known prednisolone or dexamethasone allergy, immunosuppressive disease or treatment, steroid therapy or enrollment in the study within the previous 14 days, and a high clinical suspicion of an alternative diagnosis. A total of 1252 participants were enrolled and randomly assigned to receive dexamethasone (0.6 mg/kg; n = 410), low-dose dexamethasone (0.15 mg/kg; n = 410), or prednisolone (1 mg/kg; n = 411). Primary outcome measures included Westley Croup Score 1-hour after treatment and unscheduled medical re-attendance during the 7 days after treatment. RESULTS: CONCLUSIONS:
|
Authors | Colin M Parker, Matthew N Cooper |
Journal | Pediatrics
(Pediatrics)
Vol. 144
Issue 3
(09 2019)
ISSN: 1098-4275 [Electronic] United States |
PMID | 31416827
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 by the American Academy of Pediatrics. |
Chemical References |
- Glucocorticoids
- Dexamethasone
- Prednisolone
|
Topics |
- Administration, Oral
- Child, Preschool
- Croup
(drug therapy)
- Dexamethasone
(administration & dosage, adverse effects, therapeutic use)
- Double-Blind Method
- Drug Administration Schedule
- Emergency Service, Hospital
- Equivalence Trials as Topic
- Female
- Glucocorticoids
(administration & dosage, adverse effects, therapeutic use)
- Humans
- Infant
- Male
- Prednisolone
(administration & dosage, adverse effects, therapeutic use)
- Prospective Studies
- Western Australia
|